But when it came to the secondary endpoint of interim overall survival (OS), the ITM-11 cohort reached 63.4 months while the ...

In this randomized controlled trial, cabozantinib significantly improved progression-free survival in patients with ...

Furthermore, the researchers used univariate and multivariate analyses to show that FDG-PET could be used to predict survival in patients with neuroendocrine tumors. “As a rare type of cancer it ...

One cancer survivor in Saratoga Springs shared how ... She was diagnosed with neuroendocrine cancer, which she said is a rare type of pancreatic cancer. Knotek said the first surgeon she saw ...

Stomach (gastric) neuroendocrine cancer develop in neuroendocrine cells in the stomach ... And are trying to improve the diagnosis and treatment of stomach NETs. Survival depends on many different ...

Lung neuroendocrine cancers are lung cancers that develop ... People cope differently with cancer and want different information. Survival depends on many factors. So no one can tell you exactly how ...

In a comprehensive Genomic Press Viewpoint (review) article, researchers are shining a spotlight on a revolutionary approach to tackling neuroendocrine tumors (NETs), a rare but increasingly prevalent ...